Valuation: Beijing Beilu Pharmaceutical Co., Ltd.

Market Cap 465.93Cr 69Cr 60Cr 56Cr 51Cr 97Cr 6.57TCr 98Cr 658.77Cr 257.53Cr 3.28TCr 259.19Cr 253.51Cr 11TCr P/E 2024
207x
P/E 2025 44.1x
Enterprise Value 449.05Cr 67Cr 58Cr 54Cr 49Cr 94Cr 6.33TCr 95Cr 634.9Cr 248.2Cr 3.16TCr 249.8Cr 244.33Cr 10TCr EV / Sales 2024
3.29x
EV / Sales 2025 3.57x
Free-Float
56.4%
Yield 2024
0.81%
Yield 2025 -
1 day+2.04%
1 week+2.04%
Current month+2.56%
1 month-3.49%
3 months-15.42%
6 months-22.61%
Current year+0.88%
1 week 7.56
Extreme 7.56
8.11
1 month 7.15
Extreme 7.15
8.78
Current year 7.08
Extreme 7.08
11.38
1 year 7.08
Extreme 7.08
11.98
3 years 3.58
Extreme 3.58
11.98
5 years 3.58
Extreme 3.58
11.98
10 years 3.58
Extreme 3.58
14.86
Manager TitleAgeSince
Chief Executive Officer 42 11/12/2017
Director of Finance/CFO 34 01/08/2019
Chief Operating Officer 45 25/08/2022
Director TitleAgeSince
Chairman 42 01/08/2019
Chairman 48 21/03/2019
Director/Board Member 46 21/03/2019
Date Insider Type Main position Quantity % Market Cap.
14/09/21 Sell

Executive/Senior Manager

10,000 0.0025%
10/09/21 Sell

Executive/Senior Manager

77,000 0.0189%
09/06/21 Sell

Executive/Senior Manager

60,000 0.0150%
Change 5-day change 1-year change 3-year change Capi.($)
+2.04%+2.04%-17.59%+19.02% 69Cr
-0.51%-8.60%+45.08%+148.21% 99TCr
+0.20%-4.42%+49.05%+50.81% 61TCr
-0.53%-7.37%+23.64%+65.03% 43TCr
+1.19%-0.44%+40.99%+35.96% 35TCr
+0.37%-3.88%+30.62%+38.79% 29TCr
-0.55%-11.54%+3.55%+6.72% 24TCr
-6.49%-13.27%-4.15%-46.27% 21TCr
+2.94%-0.78%+29.17%+60.32% 21TCr
+3.13%+0.69%+18.11%+71.90% 17TCr
Average +0.32%-4.28%+21.85%+45.05% 35.19TCr
Weighted average by Cap. +1.42%-5.89%+33.46%+70.32%

Financials

2024 2025
Net sales 98Cr 15Cr 13Cr 12Cr 11Cr 20Cr 1.39TCr 21Cr 139.06Cr 54Cr 692.79Cr 55Cr 54Cr 2.3TCr 120.53Cr 18Cr 16Cr 14Cr 13Cr 25Cr 1.7TCr 25Cr 170.41Cr 67Cr 848.97Cr 67Cr 66Cr 2.81TCr
Net income 1.37Cr 20.22L 17.56L 16.37L 15.04L 28.44L 19Cr 28.76L 1.93Cr 75.45L 9.62Cr 75.94L 74.28L 32Cr 9.27Cr 1.37Cr 1.19Cr 1.11Cr 1.02Cr 1.93Cr 130.67Cr 1.95Cr 13Cr 5.13Cr 65Cr 5.16Cr 5.05Cr 216.43Cr
Net Debt 19Cr 2.8Cr 2.43Cr 2.27Cr 2.08Cr 3.94Cr 266.44Cr 3.98Cr 27Cr 10Cr 133.19Cr 11Cr 10Cr 441.31Cr -17Cr -2.5Cr -2.17Cr -2.02Cr -1.86Cr -3.52Cr -237.87Cr -3.56Cr -24Cr -9.33Cr -118.91Cr -9.39Cr -9.18Cr -393.99Cr
Logo Beijing Beilu Pharmaceutical Co., Ltd.
Beijing Beilu Pharmaceutical Co Ltd is a China-based company principally engaged in the research, development, production and sales of chemical drugs (including active pharmaceutical ingredients) and traditional Chinese medicine. The chemical drug business mainly focuses on the research, development, production and sales of contrast agents, hypoglycemic drugs and other products. The traditional Chinese medicine segment mainly focuses on the production and sales of central nervous system, heat-clearing and detoxifying, and tonic products. The Company's main products include gadopentetate dimeglumine injection, iohexol injection, repaglinide tablets, iohexol active pharmaceutical ingredient, Jiuwei Zhenxin Granules, Jinlianhua Granules, Qingwei Huanglian Pills and others. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
1,188
Date Price Change Volume
04/26/04 CN¥8.010 +2.04% 1,38,78,553
03/26/03 CN¥7.850 +0.51% 1,00,37,400
31/26/31 CN¥7.810 +2.63% 1,47,75,420
30/26/30 CN¥7.610 -2.69% 1,79,79,359
29/26/29 CN¥7.820 -0.38% 1,84,72,734

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300016 Stock